img

Global Neurosurgery Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neurosurgery Drug Market Research Report 2024

Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.
According to Mr Accuracy reports new survey, global Neurosurgery Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neurosurgery Drug market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neurosurgery Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
AstraZeneca
Biogen
Jhonson & Jhonson
ABBVIE
Takeda Pharmaceuticals
UCB
IPSEN
Standigm
BlueStar Genomic
Tonix Pharmaceuticals
BlackThorn Therapeutics
Quentrix
Wren Pharmaceuticals
Segment by Type
Tablets
Solution
Capsules
Others

Segment by Application


Hospital
Clinic
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Neurosurgery Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Neurosurgery Drug Market Overview
1.1 Product Overview and Scope of Neurosurgery Drug
1.2 Neurosurgery Drug Segment by Type
1.2.1 Global Neurosurgery Drug Market Value Comparison by Type (2024-2034)
1.2.2 Tablets
1.2.3 Solution
1.2.4 Capsules
1.2.5 Others
1.3 Neurosurgery Drug Segment by Application
1.3.1 Global Neurosurgery Drug Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Neurosurgery Drug Market Size Estimates and Forecasts
1.4.1 Global Neurosurgery Drug Revenue 2018-2029
1.4.2 Global Neurosurgery Drug Sales 2018-2029
1.4.3 Global Neurosurgery Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Neurosurgery Drug Market Competition by Manufacturers
2.1 Global Neurosurgery Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Neurosurgery Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Neurosurgery Drug Average Price by Manufacturers (2018-2024)
2.4 Global Neurosurgery Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Neurosurgery Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurosurgery Drug, Product Type & Application
2.7 Neurosurgery Drug Market Competitive Situation and Trends
2.7.1 Neurosurgery Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurosurgery Drug Players Market Share by Revenue
2.7.3 Global Neurosurgery Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurosurgery Drug Retrospective Market Scenario by Region
3.1 Global Neurosurgery Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Neurosurgery Drug Global Neurosurgery Drug Sales by Region: 2018-2029
3.2.1 Global Neurosurgery Drug Sales by Region: 2018-2024
3.2.2 Global Neurosurgery Drug Sales by Region: 2024-2029
3.3 Global Neurosurgery Drug Global Neurosurgery Drug Revenue by Region: 2018-2029
3.3.1 Global Neurosurgery Drug Revenue by Region: 2018-2024
3.3.2 Global Neurosurgery Drug Revenue by Region: 2024-2029
3.4 North America Neurosurgery Drug Market Facts & Figures by Country
3.4.1 North America Neurosurgery Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Neurosurgery Drug Sales by Country (2018-2029)
3.4.3 North America Neurosurgery Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurosurgery Drug Market Facts & Figures by Country
3.5.1 Europe Neurosurgery Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Neurosurgery Drug Sales by Country (2018-2029)
3.5.3 Europe Neurosurgery Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurosurgery Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Neurosurgery Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Neurosurgery Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Neurosurgery Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Neurosurgery Drug Market Facts & Figures by Country
3.7.1 Latin America Neurosurgery Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Neurosurgery Drug Sales by Country (2018-2029)
3.7.3 Latin America Neurosurgery Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurosurgery Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurosurgery Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Neurosurgery Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Neurosurgery Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurosurgery Drug Sales by Type (2018-2029)
4.1.1 Global Neurosurgery Drug Sales by Type (2018-2024)
4.1.2 Global Neurosurgery Drug Sales by Type (2024-2029)
4.1.3 Global Neurosurgery Drug Sales Market Share by Type (2018-2029)
4.2 Global Neurosurgery Drug Revenue by Type (2018-2029)
4.2.1 Global Neurosurgery Drug Revenue by Type (2018-2024)
4.2.2 Global Neurosurgery Drug Revenue by Type (2024-2029)
4.2.3 Global Neurosurgery Drug Revenue Market Share by Type (2018-2029)
4.3 Global Neurosurgery Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Neurosurgery Drug Sales by Application (2018-2029)
5.1.1 Global Neurosurgery Drug Sales by Application (2018-2024)
5.1.2 Global Neurosurgery Drug Sales by Application (2024-2029)
5.1.3 Global Neurosurgery Drug Sales Market Share by Application (2018-2029)
5.2 Global Neurosurgery Drug Revenue by Application (2018-2029)
5.2.1 Global Neurosurgery Drug Revenue by Application (2018-2024)
5.2.2 Global Neurosurgery Drug Revenue by Application (2024-2029)
5.2.3 Global Neurosurgery Drug Revenue Market Share by Application (2018-2029)
5.3 Global Neurosurgery Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Neurosurgery Drug Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AstraZeneca Neurosurgery Drug Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Biogen
6.3.1 Biogen Corporation Information
6.3.2 Biogen Description and Business Overview
6.3.3 Biogen Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Biogen Neurosurgery Drug Product Portfolio
6.3.5 Biogen Recent Developments/Updates
6.4 Jhonson & Jhonson
6.4.1 Jhonson & Jhonson Corporation Information
6.4.2 Jhonson & Jhonson Description and Business Overview
6.4.3 Jhonson & Jhonson Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Jhonson & Jhonson Neurosurgery Drug Product Portfolio
6.4.5 Jhonson & Jhonson Recent Developments/Updates
6.5 ABBVIE
6.5.1 ABBVIE Corporation Information
6.5.2 ABBVIE Description and Business Overview
6.5.3 ABBVIE Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 ABBVIE Neurosurgery Drug Product Portfolio
6.5.5 ABBVIE Recent Developments/Updates
6.6 Takeda Pharmaceuticals
6.6.1 Takeda Pharmaceuticals Corporation Information
6.6.2 Takeda Pharmaceuticals Description and Business Overview
6.6.3 Takeda Pharmaceuticals Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Takeda Pharmaceuticals Neurosurgery Drug Product Portfolio
6.6.5 Takeda Pharmaceuticals Recent Developments/Updates
6.7 UCB
6.6.1 UCB Corporation Information
6.6.2 UCB Description and Business Overview
6.6.3 UCB Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 UCB Neurosurgery Drug Product Portfolio
6.7.5 UCB Recent Developments/Updates
6.8 IPSEN
6.8.1 IPSEN Corporation Information
6.8.2 IPSEN Description and Business Overview
6.8.3 IPSEN Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 IPSEN Neurosurgery Drug Product Portfolio
6.8.5 IPSEN Recent Developments/Updates
6.9 Standigm
6.9.1 Standigm Corporation Information
6.9.2 Standigm Description and Business Overview
6.9.3 Standigm Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Standigm Neurosurgery Drug Product Portfolio
6.9.5 Standigm Recent Developments/Updates
6.10 BlueStar Genomic
6.10.1 BlueStar Genomic Corporation Information
6.10.2 BlueStar Genomic Description and Business Overview
6.10.3 BlueStar Genomic Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 BlueStar Genomic Neurosurgery Drug Product Portfolio
6.10.5 BlueStar Genomic Recent Developments/Updates
6.11 Tonix Pharmaceuticals
6.11.1 Tonix Pharmaceuticals Corporation Information
6.11.2 Tonix Pharmaceuticals Neurosurgery Drug Description and Business Overview
6.11.3 Tonix Pharmaceuticals Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Tonix Pharmaceuticals Neurosurgery Drug Product Portfolio
6.11.5 Tonix Pharmaceuticals Recent Developments/Updates
6.12 BlackThorn Therapeutics
6.12.1 BlackThorn Therapeutics Corporation Information
6.12.2 BlackThorn Therapeutics Neurosurgery Drug Description and Business Overview
6.12.3 BlackThorn Therapeutics Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 BlackThorn Therapeutics Neurosurgery Drug Product Portfolio
6.12.5 BlackThorn Therapeutics Recent Developments/Updates
6.13 Quentrix
6.13.1 Quentrix Corporation Information
6.13.2 Quentrix Neurosurgery Drug Description and Business Overview
6.13.3 Quentrix Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Quentrix Neurosurgery Drug Product Portfolio
6.13.5 Quentrix Recent Developments/Updates
6.14 Wren Pharmaceuticals
6.14.1 Wren Pharmaceuticals Corporation Information
6.14.2 Wren Pharmaceuticals Neurosurgery Drug Description and Business Overview
6.14.3 Wren Pharmaceuticals Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Wren Pharmaceuticals Neurosurgery Drug Product Portfolio
6.14.5 Wren Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurosurgery Drug Industry Chain Analysis
7.2 Neurosurgery Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurosurgery Drug Production Mode & Process
7.4 Neurosurgery Drug Sales and Marketing
7.4.1 Neurosurgery Drug Sales Channels
7.4.2 Neurosurgery Drug Distributors
7.5 Neurosurgery Drug Customers
8 Neurosurgery Drug Market Dynamics
8.1 Neurosurgery Drug Industry Trends
8.2 Neurosurgery Drug Market Drivers
8.3 Neurosurgery Drug Market Challenges
8.4 Neurosurgery Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Neurosurgery Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Neurosurgery Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Neurosurgery Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Neurosurgery Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Neurosurgery Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Neurosurgery Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Neurosurgery Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Neurosurgery Drug Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Neurosurgery Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Neurosurgery Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurosurgery Drug, Product Type & Application
Table 12. Global Key Manufacturers of Neurosurgery Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurosurgery Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurosurgery Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurosurgery Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Neurosurgery Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Neurosurgery Drug Sales Market Share by Region (2018-2024)
Table 19. Global Neurosurgery Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Neurosurgery Drug Sales Market Share by Region (2024-2029)
Table 21. Global Neurosurgery Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Neurosurgery Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Neurosurgery Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Neurosurgery Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Neurosurgery Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Neurosurgery Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Neurosurgery Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Neurosurgery Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Neurosurgery Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Neurosurgery Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Neurosurgery Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Neurosurgery Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Neurosurgery Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Neurosurgery Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Neurosurgery Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Neurosurgery Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Neurosurgery Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Neurosurgery Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Neurosurgery Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Neurosurgery Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Neurosurgery Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Neurosurgery Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Neurosurgery Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Neurosurgery Drug Sales Market Share by Type (2018-2024)
Table 53. Global Neurosurgery Drug Sales Market Share by Type (2024-2029)
Table 54. Global Neurosurgery Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Neurosurgery Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Neurosurgery Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Neurosurgery Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Neurosurgery Drug Price (US$/Unit) by Type (2018-2024)
Table 59. Global Neurosurgery Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global Neurosurgery Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Neurosurgery Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Neurosurgery Drug Sales Market Share by Application (2018-2024)
Table 63. Global Neurosurgery Drug Sales Market Share by Application (2024-2029)
Table 64. Global Neurosurgery Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Neurosurgery Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Neurosurgery Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Neurosurgery Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Neurosurgery Drug Price (US$/Unit) by Application (2018-2024)
Table 69. Global Neurosurgery Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Neurosurgery Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. AstraZeneca Neurosurgery Drug Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Biogen Corporation Information
Table 81. Biogen Description and Business Overview
Table 82. Biogen Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Biogen Neurosurgery Drug Product
Table 84. Biogen Recent Developments/Updates
Table 85. Jhonson & Jhonson Corporation Information
Table 86. Jhonson & Jhonson Description and Business Overview
Table 87. Jhonson & Jhonson Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Jhonson & Jhonson Neurosurgery Drug Product
Table 89. Jhonson & Jhonson Recent Developments/Updates
Table 90. ABBVIE Corporation Information
Table 91. ABBVIE Description and Business Overview
Table 92. ABBVIE Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. ABBVIE Neurosurgery Drug Product
Table 94. ABBVIE Recent Developments/Updates
Table 95. Takeda Pharmaceuticals Corporation Information
Table 96. Takeda Pharmaceuticals Description and Business Overview
Table 97. Takeda Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Takeda Pharmaceuticals Neurosurgery Drug Product
Table 99. Takeda Pharmaceuticals Recent Developments/Updates
Table 100. UCB Corporation Information
Table 101. UCB Description and Business Overview
Table 102. UCB Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. UCB Neurosurgery Drug Product
Table 104. UCB Recent Developments/Updates
Table 105. IPSEN Corporation Information
Table 106. IPSEN Description and Business Overview
Table 107. IPSEN Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. IPSEN Neurosurgery Drug Product
Table 109. IPSEN Recent Developments/Updates
Table 110. Standigm Corporation Information
Table 111. Standigm Description and Business Overview
Table 112. Standigm Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Standigm Neurosurgery Drug Product
Table 114. Standigm Recent Developments/Updates
Table 115. BlueStar Genomic Corporation Information
Table 116. BlueStar Genomic Description and Business Overview
Table 117. BlueStar Genomic Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. BlueStar Genomic Neurosurgery Drug Product
Table 119. BlueStar Genomic Recent Developments/Updates
Table 120. Tonix Pharmaceuticals Corporation Information
Table 121. Tonix Pharmaceuticals Description and Business Overview
Table 122. Tonix Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Tonix Pharmaceuticals Neurosurgery Drug Product
Table 124. Tonix Pharmaceuticals Recent Developments/Updates
Table 125. BlackThorn Therapeutics Corporation Information
Table 126. BlackThorn Therapeutics Description and Business Overview
Table 127. BlackThorn Therapeutics Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. BlackThorn Therapeutics Neurosurgery Drug Product
Table 129. BlackThorn Therapeutics Recent Developments/Updates
Table 130. Quentrix Corporation Information
Table 131. Quentrix Description and Business Overview
Table 132. Quentrix Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Quentrix Neurosurgery Drug Product
Table 134. Quentrix Recent Developments/Updates
Table 135. Wren Pharmaceuticals Corporation Information
Table 136. Wren Pharmaceuticals Description and Business Overview
Table 137. Wren Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Wren Pharmaceuticals Neurosurgery Drug Product
Table 139. Wren Pharmaceuticals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Neurosurgery Drug Distributors List
Table 143. Neurosurgery Drug Customers List
Table 144. Neurosurgery Drug Market Trends
Table 145. Neurosurgery Drug Market Drivers
Table 146. Neurosurgery Drug Market Challenges
Table 147. Neurosurgery Drug Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neurosurgery Drug
Figure 2. Global Neurosurgery Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Neurosurgery Drug Market Share by Type in 2022 & 2029
Figure 4. Tablets Product Picture
Figure 5. Solution Product Picture
Figure 6. Capsules Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neurosurgery Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Neurosurgery Drug Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Neurosurgery Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Neurosurgery Drug Market Size (2018-2029) & (US$ Million)
Figure 15. Global Neurosurgery Drug Sales (2018-2029) & (K Units)
Figure 16. Global Neurosurgery Drug Average Price (US$/Unit) & (2018-2029)
Figure 17. Neurosurgery Drug Report Years Considered
Figure 18. Neurosurgery Drug Sales Share by Manufacturers in 2022
Figure 19. Global Neurosurgery Drug Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Neurosurgery Drug Players: Market Share by Revenue in 2022
Figure 21. Neurosurgery Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Neurosurgery Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Neurosurgery Drug Sales Market Share by Country (2018-2029)
Figure 24. North America Neurosurgery Drug Revenue Market Share by Country (2018-2029)
Figure 25. United States Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Neurosurgery Drug Sales Market Share by Country (2018-2029)
Figure 28. Europe Neurosurgery Drug Revenue Market Share by Country (2018-2029)
Figure 29. Germany Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Neurosurgery Drug Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Neurosurgery Drug Revenue Market Share by Region (2018-2029)
Figure 36. China Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Neurosurgery Drug Sales Market Share by Country (2018-2029)
Figure 46. Latin America Neurosurgery Drug Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Neurosurgery Drug Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Neurosurgery Drug Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Neurosurgery Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Neurosurgery Drug by Type (2018-2029)
Figure 56. Global Revenue Market Share of Neurosurgery Drug by Type (2018-2029)
Figure 57. Global Neurosurgery Drug Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Neurosurgery Drug by Application (2018-2029)
Figure 59. Global Revenue Market Share of Neurosurgery Drug by Application (2018-2029)
Figure 60. Global Neurosurgery Drug Price (US$/Unit) by Application (2018-2029)
Figure 61. Neurosurgery Drug Value Chain
Figure 62. Neurosurgery Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries